Knowledge Hub

A structured library of practical guidance across GMP compliance, investigations, documentation, audits, supplier quality, and risk-based decision-making.

VerethiQ organizes pharmaceutical quality systems into six connected domains to support clearer execution, stronger compliance, and better operational decisions across regulated environments.

Krupa Dubey 6/17/26 Krupa Dubey 6/17/26

Detectability in QRM

Detectability is more than the presence of control. This article explains how GMP systems evaluate actual monitoring capability, control reliability, and operational visibility.

Krupa Dubey 6/15/26 Krupa Dubey 6/15/26

RPN Limitations & Alternatives

RPN scoring helps prioritize risk, but multiplication-based systems can create false precision and weak prioritization. This article explains common RPN limitations and better alternatives.

Krupa Dubey 6/13/26 Krupa Dubey 6/13/26

Risk Scoring Systems Explained

Risk scoring systems help GMP organizations prioritize oversight and escalation. This article explains severity, occurrence, detectability, weighting logic, and common scoring failures.

Krupa Dubey 6/10/26 Krupa Dubey 6/10/26

Risk Matrices: Pros & Cons

Risk matrices help GMP organizations prioritize and communicate risk. This article explains their benefits, limitations, scoring challenges, and inspection expectations.

Krupa Dubey 6/8/26 Krupa Dubey 6/8/26

HACCP & Hazard Analysis

HACCP helps GMP organizations identify and control hazards before they impact product quality or patient safety. This guide explains CCPs, monitoring, corrective actions, and reassessment.

Krupa Dubey 6/6/26 Krupa Dubey 6/6/26

FMEA Step-by-Step

FMEA helps GMP organizations identify and prioritize potential failures before they occur. This guide explains step-by-step execution, scoring logic, mitigation, and inspection expectations.

Krupa Dubey 6/3/26 Krupa Dubey 6/3/26

Risk vs Uncertainty in GMP

Understanding the difference between risk and uncertainty is critical for effective QRM. This article explains how confusion between the two leads to weak decisions and inspection risk.

Krupa Dubey 6/1/26 Krupa Dubey 6/1/26

Risk Demonstration in GMP

Regulators do not assess risk through templates - they assess decisions. This article explains how risk is evaluated during inspection and what signals effective QRM.

Krupa Dubey 5/30/26 Krupa Dubey 5/30/26

QRM Terminology Explained

QRM terminology shapes how risk-based decisions are made. This article explains how key terms are interpreted in practice and why inconsistency leads to weak decisions.

Krupa Dubey 5/26/26 Krupa Dubey 5/26/26

Risk Management Process Steps

Understand the step-by-step risk management process in GMP systems and how regulators expect it to be applied in practice.

Krupa Dubey 5/26/26 Krupa Dubey 5/26/26

ICH Q9 Explained

ICH Q9 defines how risk-based decisions should be made in GMP systems. This guide explains its principles, process, and what regulators actually expect in practice.

Krupa Dubey 4/30/26 Krupa Dubey 4/30/26

Staying Current with GMP Changes

GMP regulations change slowly, but inspection emphasis evolves continuously. This article explains how to build a structured regulatory monitoring and review process that keeps quality systems aligned without unnecessary disruption.